company background image
APH logo

Ampio Pharmaceuticals DB:APH Stock Report

Last Price

€3.62

Market Cap

€1.5m

7D

0%

1Y

n/a

Updated

09 Dec, 2023

Data

Company Financials

Ampio Pharmaceuticals, Inc.

DB:APH Stock Report

Market Cap: €1.5m

APH Stock Overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.

APH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Ampio Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ampio Pharmaceuticals
Historical stock prices
Current Share PriceUS$3.62
52 Week HighUS$7.40
52 Week LowUS$2.48
Beta2.35
1 Month Change0%
3 Month Change7.10%
1 Year Changen/a
3 Year Change-81.53%
5 Year Change-49.58%
Change since IPO-94.09%

Recent News & Updates

Recent updates

Shareholder Returns

APHDE PharmaceuticalsDE Market
7D0%2.3%1.9%
1Yn/a-25.9%7.3%

Return vs Industry: Insufficient data to determine how APH performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how APH performed against the German Market.

Price Volatility

Is APH's price volatile compared to industry and market?
APH volatility
APH Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: APH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine APH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a5Mike Martinohttps://ampiopharma.com

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.

Ampio Pharmaceuticals, Inc. Fundamentals Summary

How do Ampio Pharmaceuticals's earnings and revenue compare to its market cap?
APH fundamental statistics
Market cap€1.47m
Earnings (TTM)-€8.17m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
APH income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$8.80m
Earnings-US$8.80m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-10.57
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did APH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.